Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors

figure chart

A multi-institution team of researchers led by Mohammad Ghazi Vakili (University of Toronto) and Christoph Gorgulla (St. Jude Children’s Research Hospital and Harvard University) reported using a hyrbid quantum-classical workflow to identify KRAS inhibitor drug candidates. KRAS is a well-known cancer causing gene.

The post Researchers Use Hybrid Quantum-Classical Workflow to Identify KRAS Inhibitors appeared first on HPCwire.

More Related Posts

How CreateMe Robotics is changing the apparel industry | The Robot Report

Cam Myers, founder and CEO of CreateMe, discusses the innovative application of...

6 Ways Cloud Robotics Will Change the World

Robots teaching robots. It’s a time-tested science fiction trope, guaranteed to strike...

How Amazon robotics engineers continue to build technologies from their garages

Team members in Boulder loading equipment to move to their homes. Source:...

Home

Highly Niched Headhunters Specialized in Physical AI/Robotics, High-Performance Computing, Unmanned/Autonomous Systems, Defense Technology and Energy.

Specializations

We recruit across complex engineering markets where understanding the technology is critical to finding the right talent.

How We Work

Overview of how PACE partners with teams: Our process, what clients get, and why PACE is different.

About Us

PACE’s story, values, and culture define how we operate and who we are.

News & Insights

Stay up to date on industry trends.

Contact

All the information needed for anyone interested in contacting us.